Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 43598-430

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 43598-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

This is a prescription drug called Dimethyl Fumarate, Delayed-Release Capsules, used to treat multiple sclerosis. The usual dosage recommended is one capsule taken orally twice a day. Each capsule contains 120mg of dimethyl fumarate. The drug should be stored at a temperature between 15°C to 30°C and protected from light. The package comes with 14 capsules, and it should be dispensed in its original package. The prescription was issued in May 2020.*

FDA Label Image

Carton2 (Carton2)

This is a medication called Ethyl Fumarate which comes in Delayed-Release Capsules with a dosage of 240mg. Each capsule has to be swallowed whole and is recommended to take one capsule twice a day. The medication should be stored at a dry and cool place at 15°C to 30°C (59°F to 86°F) and should be protected from light. This medication is available in a package of 60 capsules and distributed by Dr. Reddy’s Laboratories Inc. The rest of the text is illegible.*

FDA Label Image

Container1 (Container1)

This is a medicine package of Dimethyl Fumarate Delayed-Release Capsules, including 18 capsules with each capsule containing 120mg of the medicine. The package includes a LOT number and EXP date of the medicine, which are necessary details to be checked before use. The packaging includes a variable coding area, and the text may be over-coded during packing.*

FDA Label Image

Container2 (Container2)

The text contains information about coding area, LOT and EXP details along with variable data. However, there is not enough information or context to provide a useful description.*

FDA Label Image

Figure1 (Figure1)

This appears to be a graph showing the results of a study on a medication's effectiveness in preventing disability progression related to a disease. The x-axis shows the time on the study in weeks and the y-axis shows the percentage of participants with confirmed progression of disability. The study involved a placebo group and a group taking the medication dimethyl fumarate twice daily at a dose of 240mg. The text provides details on the criteria for confirmed progression of disability.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.